Assesment of P wave duration and dispersion in Parkinson's disease
Progress in Neuro-Psychopharmacology and Biological Psychiatry, cilt.30, sa.4, ss.718-723, 2006 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 30 Sayı: 4
- Basım Tarihi: 2006
- Doi Numarası: 10.1016/j.pnpbp.2006.02.011
- Dergi Adı: Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.718-723
- Anahtar Kelimeler: atrial arrhythmia, Parkinson's disease, P wave dispersion, P wave duration
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Cardiovascular disorders such as decreased heart rate variability, orthostatic hypotension, and arrhythmias have been frequently observed in Parkinson's disease (PD) patients. In this study, authors measured P wave duration and dispersion in PD patients and controls. Twenty-three consecutive patients with idiopathic PD and sex-age matched 23 control subjects were included to the study. A 12-lead surface ECG was obtained from each participant. Maximum-minimum P wave duration and P wave dispersion (PWD) were measured in both groups. Maximum P wave duration was found to be higher in PD patients than controls (117 ± 12 vs. 105 ± 9 ms p = 0.001). Minimum P wave duration was similar in PD patients and controls (64 ± 11 vs. 63 ± 11 ms p = 0.7). PWD in PD patients was also found to be higher than those of controls (53 ± 11 vs. 43 ± 10 ms p = 0.0001). P wave duration and PWD did not significantly differ between PD patients taking anti-parkinsonian agents from those who were not (119 ± 13 vs. 116 ± 13 ms p = 0.4 and 55 ± 11 vs. 52 ± 11 ms p = 0.5, respectively). Moreover, when the PD patients taking anti-parkinsonian agents were excluded from the study, PD patients had still higher P wave duration and PWD compared to controls (119 ± 11 vs. 105 ± 9 ms p = 0.004, 52 ± 10 vs. 43 ± 10 ms p = 0.009, respectively). In conclusion, we found that P wave duration and PWD were greater in PD patients compared to control subjects. © 2006 Elsevier Inc. All rights reserved.